In the era of effective systemic therapy and precise radiotherapy. neoadjuvant treatment (NAT) for breast cancer can de-escalate breast cancer treatment to conserve breast and spare axillary lymph node dissection (ALND). At present. high axillary nodal pathologic complete response (apCR) is achieved in patients with human epidermal growth factor receptor 2 (HER2)-positive and triple-n... https://www.incredibleindiatourtravels.com/